FdaApplication

ANDA 218195

Back to search

Identifiers

Properties

PropertyValue
applicant_nameLUPIN LTD
application_typeANDA
approval_date2025-09-25

Products (1)

ProductActive ingredientStrengthDosage form
RIVAROXABANRIVAROXABAN1MG/MLFOR SUSPENSION;ORAL

1 product